Cargando…

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression

Interactions of the receptor for advanced glycation end product (RAGE) and its ligands in the context of their role in diabetes mellitus, inflammation, and carcinogenesis have been extensively investigated. This review focuses on the role of RAGE-ligands and anti-RAGE drugs capable of controlling ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Far, Ali H., Sroga, Grazyna, Al Jaouni, Soad K., Mousa, Shaker A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279268/ https://www.ncbi.nlm.nih.gov/pubmed/32443845 http://dx.doi.org/10.3390/ijms21103613

Ejemplares similares

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
por: Sparvero, Louis J, et al.
Publicado: (2009)

Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases
por: El-Far, Ali H., et al.
Publicado: (2018)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

RAGE ligands stimulate angiotensin II type I receptor (AT1) via RAGE/AT1 complex on the cell membrane
por: Yokoyama, Serina, et al.
Publicado: (2021)

Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer
por: Godugu, Kavitha, et al.
Publicado: (2020)

Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
por: Godugu, Kavitha, et al.
Publicado: (2022)

RAGE Inhibitors in Neurodegenerative Diseases
por: Reddy, V. Prakash, et al.
Publicado: (2023)

Role of RAGE and Its Ligands on Inflammatory Responses to Brain Tumors
por: Otazu, Griffith Kyle, et al.
Publicado: (2021)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro
por: Miller, Suzanne, et al.
Publicado: (2016)

All the rage
por: Ostertag, Bob, 1957-
Publicado: (1993)

Controlling RAGE
por: Van Epps, Heather L.
Publicado: (2005)

Black Rage
por: Hirsch, Steven
Publicado: (1969)

Raging Diseases
Publicado: (1870)

Rage and Ruin
Publicado: (1880)

Rage and Ruin
Publicado: (1877)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE
por: Li, Miaomiao, et al.
Publicado: (2022)

Progress of RAGE Molecular Imaging in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2020)

RAGE signaling regulates the progression of diabetic complications
por: Taguchi, Kensei, et al.
Publicado: (2023)

Targeting RAGE in sepsis
por: van Zoelen, Marieke AD, et al.
Publicado: (2008)

La rage littéraire /
por: Mandelstam, Osip, 1891-1938
Publicado: (1972)

Is RAGE the receptor for inflammaging?
por: Frimat, Marie, et al.
Publicado: (2019)

Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk
por: Chiappalupi, Sara, et al.
Publicado: (2021)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy
por: Olejarz, Wioletta, et al.
Publicado: (2018)

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases
por: Lee, Eun Ji, et al.
Publicado: (2013)

Pyrogallol-Phloroglucinol-6,6-Bieckol Alleviates Obesity and Systemic Inflammation in a Mouse Model by Reducing Expression of RAGE and RAGE Ligands
por: Choi, Junwon, et al.
Publicado: (2019)

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
por: Humpert, Per M, et al.
Publicado: (2007)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
por: Eleazu, Chinedum, et al.
Publicado: (2019)

Regulation of RAGE for Attenuating Progression of Diabetic Vascular Complications
por: Win, Myat Thu Thu, et al.
Publicado: (2012)

Virtual screening of RAGE inhibitors using molecular docking
por: Devi Alaparthi, Malini, et al.
Publicado: (2016)

Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors
por: Kim, Hyeon Jin, et al.
Publicado: (2021)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
por: González-Guerrero, Diana Elizabeth, et al.
Publicado: (2023)

Age dependent accumulation patterns of advanced glycation end product receptor (RAGE) ligands and binding intensities between RAGE and its ligands differ in the liver, kidney, and skeletal muscle
por: Son, Myeongjoo, et al.
Publicado: (2017)

A fierce storm rages.
por: Boyes, J
Publicado: (1972)

RAGE in the pathophysiology of skeletal muscle
por: Riuzzi, Francesca, et al.
Publicado: (2018)

RAGE Signaling in Melanoma Tumors
por: Olaoba, Olamide T., et al.
Publicado: (2020)

Long COVID: “And the fire rages on”
por: Rajkumar Tripathi, Awatansh Kumar, et al.
Publicado: (2021)

Pathophysiology of RAGE in inflammatory diseases
por: Dong, Hanbing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_52nrcmu0v48os8v87c5udku8nk